Natural language processing and social listening are transforming various aspects of modern business operations – and life science is no exception.
The time is right for medical affairs to address vulnerabilities in existing operating models and invest in technologies that strengthen the organization.
Life science companies should look at a modern, tech-enabled process for gathering insight.
Life science companies can use technology to correct drug development and healthcare inequalities.
Adopting solutions that provide human-centric knowledge will be the key to increasing the value generated from the pharmaceutical industry’s tech investment.
Within3 CTO, AI & Analytics Jason Smith talks to Pharmafield about AI technology in pharma, wearables, the impact of social media, and more.
How patient-centered strategies are changing clinical trials, and how life science companies can implement more patient-focused tactics.
Within3’s Vice President of Product Commercialization and Training, Natalie DiMambro, talks to Outsourcing Pharma about incorporating patient voice in clinical trials.
The amplified iteration of the platform transforms the potential for market visibility, research collaboration, and business decision-making in life science.
Within3 CTO, AI & Analytics Jason Smith talks to European Pharmaceutical Manufacturer about the possibilities of AI innovation in life science.
